Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice

Toxicology and Applied Pharmacology

Volumn 193, Issue 2, 2003, Pages 218-227

  Chiu, Hawjyh ^a   Gardner, Carol R ^a   Dambach, Donna M ^a,b   Durham, Stephen K ^b   Brittingham, Jennie A ^a   Laskin, Jeffrey D ^a   Laskin, Debra L ^a,c  

^a RUTGERS UNIVERSITY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Acetaminophen; Cyclins; p21; PI 3K; STAT3; TNF ; TNFR1

Indexed keywords

CYTOKINE; PARACETAMOL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT3 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; LIVER CELL; LIVER TOXICITY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE INJURY; WILD TYPE;

EID: 0345687490     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.07.003     Document Type: Article

References (54)

1. Adams P.D. Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim. Biophys. Acta. 1471:2001;M123-M133.
2. Akerman P., Cote P., Yang S.Q., McClain C., Nelson S., Bagby G.J., Diehl A.M. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263:1992;G579-G585.
3. Allan A.L., Albanese C., Pestell R.G., LaMarre J. Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes. J. Biol. Chem. 276:2001;27272-27280.
4. Baldin V., Lukas J., Marcote M.J., Pagano M., Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:1993;812-821.
5. Blazka M.E., Germolec D.R., Simeonova P., Bruccoleri A., Pennypacker K.R., Luster M.I. Acetaminophen-induced hepatotoxicity is associated with early changes in NF-κB and NF-IL6 DNA binding activity. J. Inflamm. 47:1995;138-150.
6. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling a hard Akt to follow . Trends Biochem. Sci. 26:2001;657-664.
7. Bromberg J., Darnell J.E. The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 19:2000;2468-2473.
8. Calabrese E.J., Baldwin L.A., Mehendale H.M. G2 subpopulation in rat liver induced into mitosis by low-level exposure to carbon tetrachloride an adaptive response . Toxicol. Appl. Pharmacol. 121:1993;1-7.
9. Cantley L.C. The phosphoinositide 3-kinase pathway. Science. 296:2002;1655-1657.
10. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., de Falco A., Lombardi M., Fiorentino R., Varricchio L., Barone M.V., Auricchio F. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20:2001;6050-6059.
11. Chanda S., Mangipudy R.S., Warbritton A., Bucci T.J., Mehendale H.M. Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality. Hepatology. 21:1995;477-486.
12. Chanda S., Mehendale H.M. Hepatic cell division and tissue repair a key to survival after liver injury . Mol. Med. Today. 2:1996;82-89.
13. Chanda S., Mehendale M. Role of nutritional fatty acid and L-carnitine in the final outcome of thioacetamide hepatotoxicity. FASEB J. 8:1994;1061-1068.
14. Chiu, H., Gardner, C.R., Dambach, D.M., Brittingham, J.A., Durham, S.K., Laskin, J.D., Laskin, D.L., 2003. Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense. Am. J. Physiol., in press.
15. Clement A., Henrion-Caude A., Besnard V., Corroyer S. Role of cyclins in epithelial response to oxidants. Am. J. Respir. Crit. Care Med. 164:2001;S81-S84.
16. Cressman D.E., Greenbaum L.E., DeAngelis R.A., Ciliberto G., Furth E.E., Poli V., Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1996;1379-1383.
17. Debonera F., Aldeguer X., Shen X., Gelman A.E., Gao F., Que X., Greenbaum L.E., Furth E.E., Taub R., Olthoff K.M. Activation of interleukin-6/STAT3 and liver regeneration following transplantation. J. Surg. Res. 96:2001;289-295.
18. Diehl J.A., Cheng M., Roussel M.F., Sherr C.J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:1998;3499-3511.
19. Dotto G.P. p21(WAF1/Cip1) more than a break to the cell cycle . Biochim. Biophys. Acta. 1471:2000;M43-M56.
20. Fausto N. Liver regeneration. J. Hepatol. 32:2000;19-31.
21. Gardner, C.R., Laskin, J.D., Dambach, D.M., Chiu, H., Durham, S.K., Zhou, P., Bruno, M., Gerecke, D.R., Gordon, M.K., Laskin, D.L., 2003. Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor-1 receptor: potential role of inflammatory mediators. Toxicol. Appl. Pharmacol., in press.
22. Gartel A.L., Serfas M.S., Tyner A.L. p21 negative regulator of the cell cycle . Proc. Soc. Exp. Biol. Med. 213:1996;138-149.
23. Grana X., Reddy E.P. Cell cycle control in mammalian cells role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs) . Oncogene. 11:1995;211-219.
24. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., Baldwin A.S. Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19:1999;5785-5799.
25. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
26. Harper J.W., Adams P.D. Cyclin-dependent kinases. Chem. Rev. 101:2001;2511-2526.
27. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., Strauss M. NF-kappaB function in growth control regulation of cyclin D1 expression and G0/G1-to-S-phase transition . Mol. Cell. Biol. 19:1999;2690-2698.
28. Holecek M., Simek J., Palicka V., Zadak Z. Effect of glucose and branched chain amino acid (BCAA) infusion on onset of liver regeneration and plasma amino acid pattern in partially hepatectomized rats. J. Hepatol. 13:1991;14-20.
29. Hui T.T., Mizuguchi T., Sugiyama N., Avital I., Rozga J., Demetriou A.A. Immediate early genes and p21 regulation in liver of rats with acute hepatic failure. Am. J. Surg. 183:2002;457-463.
30. Ishida Y., Kondo T., Ohshima T., Fujiwara H., Iwakura Y., Mukaida N. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 16:2002;1227-1236.
31. Joyce D., Albanese C., Steer J., Fu M., Bouzahzah B., Pestell R.G. NF-kappaB and cell-cycle regulation the cyclin connection . Cytokine Growth Factor Rev. 12:2001;73-90.
32. 4 in chlordecone-pretreated rats. Exp. Mol. Pathol. 39:1983;1-10.
33. 4 lethality by chlordecone. Toxicol. Lett. 11:1982;149-154.
34. Kovalovich K., DeAngelis R.A., Li W., Furth E.E., Ciliberto G., Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology. 31:2000;149-159.
35. Levy D.E., Darnell J.E. Stats transcriptional control and biological impact . Nat. Rev. Mol. Cell Biol. 3:2002;651-662.
36. Li W., Liang X., Leu J.I., Kovalovich K., Ciliberto G., Taub R. Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology. 33:2001;1377-1386.
37. Lukas J., Pagano M., Staskova Z., Draetta G., Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene. 9:1994;707-718.
38. Mangipudy R.S., Chanda S., Mehendale H.M. Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ. Health Perspect. 103:1995;260-267.
39. Masubuchi Y., Bourdi M., Reilly T.P., Graf M.L., George J.W., Pohl L.R. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem. Biophys. Res. Commun. 304:2003;207-212.
40. Mehendale H.M., Thakore K.N., Rao C.V. Autoprotection stimulated tissue repair permits recovery from injury . J. Biochem. Toxicol. 9:1994;131-139.
41. Michalopoulos G.K., DeFrances M.C. Liver regeneration. Science. 276:1997;60-66.
42. Morgan D.O. Cyclin-dependent kinases engines, clocks, and microprocessors . Annu. Rev. Cell Dev. Biol. 13:1997;261-291.
43. Pestell R.G., Albanese C., Reutens A.T., Segall J.E., Lee R.J., Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr. Rev. 20:1999;501-534.
44. Pines J. Cell cycle confirmational change . Nature. 376:1995;294-295.
45. Serfas M.S., Goufman E., Feuerman M.H., Gartel A.L., Tyner A.L. p53-independent induction of p21WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication. Cell Growth Differ. 8:1997;951-961.
46. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
47. Tygstrup N., Jensen S.A., Krog B., Dalhoff K. Expression of liver-specific functions in rat hepatocytes following sublethal and lethal acetaminophen poisoning. J. Hepatol. 25:1996;183-190.
48. Vanden Berghe W., Vermeulen L., De Wilde G., De Bosscher K., Boone E., Haegeman G. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem. Pharmacol. 60:2000;1185-1195.
49. Vemuri G.S., Rittenhouse S.E. Wortmannin inhibits serum-induced activation of phosphoinositide 3-kinase and proliferation of CHRF-288 cells. Biochem. Biophys. Res. Commun. 202:1994;1619-1623.
50. Webber E.M., Bruix J., Pierce R.H., Fausto N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology. 28:1998;1226-1234.
51. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
52. Yamada Y., Fausto N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am. J. Pathol. 152:1998;1577-1589.
53. Yamada Y., Kirillova I., Peschon J.J., Fausto N. Initiation of liver growth by tumor necrosis factor deficient liver regeneration in mice lacking type I tumor necrosis factor receptor . Proc. Natl. Acad. Sci. USA. 94:1997;1441-1446.
54. Yamada Y., Webber E.M., Kirillova I., Peschon J.J., Fausto N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor requirement for type 1 but not type 2 receptor . Hepatology. 28:1998;959-970.